Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Neurology

What Are the Best Medications for CMT1A Nerve Pain?

At a Glance

The best medications for CMT1A nerve pain are prescription drugs like gabapentin, pregabalin, and duloxetine. Over-the-counter painkillers like ibuprofen do not work for nerve pain. These daily prescriptions calm damaged nerves to reduce burning, tingling, and electrical sensations.

Because Charcot-Marie-Tooth disease type 1A (CMT1A) directly affects the peripheral nerves, standard over-the-counter painkillers are often ineffective for the burning and tingling sensations it causes [1][2]. The most effective medications for this specific type of nerve pain (neuropathic pain) belong to classes originally developed to treat seizures or depression, such as gabapentin, pregabalin, duloxetine, and amitriptyline [2].

While researchers are investigating therapies targeting the underlying cause of CMT1A, there are currently no pain medications specifically designed just for CMT [1]. However, doctors successfully manage nerve pain in CMT1A using standard protocols for peripheral neuropathy [2].

Understanding the Two Types of CMT1A Pain

Pain is a recognized and common symptom in CMT [3]. For most people living with CMT1A, pain usually falls into a “mixed pattern” containing two distinct types: neuropathic and nociceptive (biomechanical) pain [4].

  • Neuropathic Pain: This is direct nerve pain caused by the disease damaging the myelin sheath around your peripheral nerves. Patients often describe this as a burning, tingling, “pins and needles,” or electrical shock sensation [4][5].
  • Biomechanical (Nociceptive) Pain: This is structural or physical pain. As CMT causes muscle weakness, foot drop, or high arches, it changes the way you walk and stand [6]. This puts unnatural stress on your ankles, knees, hips, and back, leading to aching joints and muscles [7].

Understanding which type of pain you are experiencing is crucial because they require completely different treatments.

Best Medications for Nerve Pain

To treat the burning, electrical, and tingling sensations of neuropathic pain, doctors rely on prescription medications that calm down overactive nerve signaling [8].

Important Note on Timeline: Unlike over-the-counter painkillers that you take “as-needed” for immediate relief, neuropathic pain medications must be taken daily. It often takes several weeks for the drug to build up in your system before you experience meaningful pain relief [2][9].

1. Gabapentinoids (Anti-seizure Medications)

Originally developed for epilepsy, these medications are widely considered a first-line treatment for peripheral nerve pain [8][9]. They work by slowing down the electrical signals in damaged nerves.

  • Gabapentin (Neurontin)
  • Pregabalin (Lyrica)

2. Antidepressants for Pain Management

Certain medications originally developed for depression are very effective at treating nerve pain, even in patients who do not have depression [2]. They increase levels of neurotransmitters (like serotonin and norepinephrine) in the spinal cord, which helps block pain signals before they reach the brain.

  • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors): such as Duloxetine (Cymbalta) [2][9].
  • TCAs (Tricyclic Antidepressants): such as Amitriptyline [2][9].

3. Topical Treatments

For localized burning in the feet, doctors may prescribe topical treatments like lidocaine patches or capsaicin creams [10]. These are applied directly to the skin and are a good option for patients looking to minimize systemic side effects.

Side Effects and Fall Risks

Because peripheral nerve pain management needs to be individualized, you and your doctor will work to find the right medication with the fewest side effects [11][10].

Common side effects of both gabapentinoids and systemic antidepressants include dizziness, drowsiness (somnolence), and “brain fog.” For patients with CMT1A, this is critical: dizziness can significantly increase your risk of falling [8]. Since CMT already causes foot drop and balance instability, you must monitor carefully for dizziness when starting a new medication or adjusting your dose.

Additionally, TCAs like amitriptyline can cause anticholinergic side effects (such as dry mouth, constipation, and cognitive issues). For this reason, they are often used with caution in older adults, who may prefer to try SNRIs, gabapentinoids, or topical treatments first [8][10].

Why Over-The-Counter Painkillers Don’t Fix Nerve Pain

If your feet are burning and you reach for an over-the-counter NSAID (Non-Steroidal Anti-Inflammatory Drug) like ibuprofen or naproxen, you will likely be disappointed. NSAIDs work by blocking specific enzymes (cyclooxygenase, or COX) to reduce inflammation and tissue swelling [12][13][14].

Because neuropathic pain is caused by nerve misfiring—not inflammation—NSAIDs do not target the root cause of nerve pain.

However, NSAIDs can be highly effective for treating the secondary biomechanical pain you may experience. If your knees or lower back are aching from walking with foot drop, NSAIDs can help reduce that structural inflammation [14].

Non-Medication Pain Management

Management of pain in CMT1A is usually multimodal, meaning it combines drugs with physical interventions [11]. Because a large part of CMT pain is biomechanical, using orthotic bracing—like Ankle-Foot Orthoses (AFOs)—custom orthopedic shoes, and physical therapy are proven ways to improve your gait, increase walking endurance, and reduce musculoskeletal pain [6][15].

Low-impact exercises (like swimming) and weight management are also critical, as reducing body weight directly decreases the biomechanical stress on weakened ankles and knees [6].

Safety Warning: Neurotoxic Drugs

While treating your pain, be aware that some specific non-pain drugs—most notably certain chemotherapies like vincristine and paclitaxel—are severely neurotoxic and can drastically worsen CMT neuropathy. Always ensure any doctor prescribing you a new medication knows you have CMT1A [16][17].

Common questions in this guide

Why don't over-the-counter painkillers work for my burning feet?
Over-the-counter medications like ibuprofen and naproxen are designed to reduce inflammation and tissue swelling. Because the burning pain in CMT1A is caused by damaged nerves misfiring rather than inflammation, these medications do not target the root cause of nerve pain.
What is the difference between neuropathic and biomechanical pain in CMT1A?
Neuropathic pain is caused by direct nerve damage, resulting in burning, tingling, or electrical shock sensations. Biomechanical pain is physical aching in the joints and muscles caused by unnatural stress on your body from walking differently due to foot drop or muscle weakness.
How long does it take for nerve pain medication to start working?
Unlike over-the-counter pain relievers that provide immediate relief, prescription medications for nerve pain must be taken daily. It often takes several weeks for the medication to build up in your system before you experience meaningful pain reduction.
What are the risks of taking nerve pain medications if I have CMT1A?
A primary side effect of nerve pain medications like gabapentin or amitriptyline is dizziness and drowsiness. Because CMT1A already causes balance instability and muscle weakness, these side effects must be monitored closely as they can significantly increase your risk of falling.
Are there topical treatments for CMT1A nerve pain?
Yes, if you experience localized burning in your feet, doctors may prescribe topical treatments like lidocaine patches or capsaicin creams. These are applied directly to the skin and can provide targeted relief with fewer full-body side effects than oral medications.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my symptoms, is my pain primarily neuropathic, biomechanical, or a mix of both?
  2. 2.Given my current level of balance and muscle weakness, which nerve pain medication offers the lowest risk for dizziness and falls?
  3. 3.Should I start with a topical treatment like lidocaine before trying a systemic oral medication?
  4. 4.How long should I expect to take this prescribed medication daily before we know if it is effectively reducing my nerve burning?
  5. 5.Would a referral to an orthotist for Ankle-Foot Orthoses (AFOs) help reduce the secondary biomechanical pain I am experiencing in my joints?
  6. 6.Are any of the medications I am currently taking for other conditions considered neurotoxic or risky for someone with CMT1A?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    The current status of Charcot-Marie-Tooth disease type 1 A treatment.

    Qi H, Wang X, Wu B, et al.

    Acta neurologica Belgica 2025; (125(6)):1525-1533 doi:10.1007/s13760-025-02881-1.

    PMID: 40864398
  2. 2

    [Update in the pharmacological treatment of neuropathic pain].

    Alcántara Montero A, Ibor Vidal PJ, Alonso Verdugo A, Trillo Calvo E

    Semergen 2019; (45(8)):535-545 doi:10.1016/j.semerg.2019.05.008.

    PMID: 31337589
  3. 3

    Neuropathic pain in Charcot-Marie-Tooth disease: A clinical and laser-evoked potential study.

    Peretti A, Squintani G, Taioli F, et al.

    European journal of pain (London, England) 2022; (26(4)):929-936 doi:10.1002/ejp.1922.

    PMID: 35129250
  4. 4

    Prevalence and characterization of pain in patients with Charcot-Marie-Tooth disease type 1A.

    Azevedo H, Costa H, Davidovich E, et al.

    Arquivos de neuro-psiquiatria 2021; (79(5)):415-419 doi:10.1590/0004-282X-ANP-2020-0132.

    PMID: 34037101
  5. 5

    Pain in Charcot-Marie-Tooth disease: an update.

    Azevedo H, Pupe C, Pereira R, Nascimento OJM

    Arquivos de neuro-psiquiatria 2018; (76(4)):273-276 doi:10.1590/0004-282x20180021.

    PMID: 29742248
  6. 6

    Orthopaedic shoes along with physical therapy was effective in Charcot-Marie-Tooth patient over 10 years.

    Bensoussan L, Jouvion A, Kerzoncuf M, et al.

    Prosthetics and orthotics international 2016; (40(5)):636-42 doi:10.1177/0309364615584657.

    PMID: 26015326
  7. 7

    Charcot-Marie-Tooth Disease and Other Hereditary Neuropathies.

    Klein CJ

    Continuum (Minneapolis, Minn.) 2020; (26(5)):1224-1256 doi:10.1212/CON.0000000000000927.

    PMID: 33003000
  8. 8

    An overview of the non-procedural treatment options for peripheral neuropathic pain.

    Zeldin ER, Goddard AR, Boyle MS, et al.

    Muscle & nerve 2025; (71(5)):791-801 doi:10.1002/mus.28286.

    PMID: 39511948
  9. 9

    Clinical pharmacology of neuropathic pain.

    Rosner J, Attal N, Finnerup NB

    International review of neurobiology 2024; (179()):403-430 doi:10.1016/bs.irn.2024.10.012.

    PMID: 39580218
  10. 10

    Peripheral neuropathic pain: supporting patients with self-management.

    Sear C

    Nursing standard (Royal College of Nursing (Great Britain) : 1987) 2024; (39(4)):71-75 doi:10.7748/ns.2024.e12318.

    PMID: 38495010
  11. 11

    Evolving Treatment Strategies for Neuropathic Pain: A Narrative Review.

    Kaye AD, Armistead G, Amedio LS, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(6)) doi:10.3390/medicina61061063.

    PMID: 40572751
  12. 12

    Safety of Nonsteroidal Antiinflammatory Drugs.

    Felson DT

    The New England journal of medicine 2016; (375(26)):2595-6 doi:10.1056/NEJMe1614257.

    PMID: 28029923
  13. 13

    Dynamic analysis of phospholipid metabolism of mouse macrophages treated with common non-steroidal anti-inflammatory drugs.

    Peng H, Wu X, Zhao L, Feng Y

    Molecular and cellular biochemistry 2016; (411(1-2)):161-71 doi:10.1007/s11010-015-2578-9.

    PMID: 26441061
  14. 14

    Non-opioid Analgesics and the Endocannabinoid System

    Topuz RD, Gündüz Ö, Karadağ ÇH, Ulugöl A

    Balkan medical journal 2020; (37(6)):309-315 doi:10.4274/balkanmedj.galenos.2020.2020.6.66.

    PMID: 32551466
  15. 15

    Changes in walking velocity and stride parameters with age in children with Charcot-Marie-Tooth disease.

    Õunpuu S, Pierz KA, Acsadi G, Wren TAL

    Neuromuscular disorders : NMD 2020; (30(10)):825-832 doi:10.1016/j.nmd.2020.08.359.

    PMID: 32928646
  16. 16

    Toxic medications in Charcot-Marie-Tooth patients: A systematic review.

    Cavaletti G, Forsey K, Alberti P

    Journal of the peripheral nervous system : JPNS 2023; (28(3)):295-307 doi:10.1111/jns.12566.

    PMID: 37249082
  17. 17

    Heterozygosity for CMT Type 4 Predicts a Severe Vincristine-induced Polyneuropathy Phenotype: A Case Report and Review of Literature.

    Sy A, Cheng J, Cooper R, Mueller L

    Journal of pediatric hematology/oncology 2019; (41(1)):e41-e43 doi:10.1097/MPH.0000000000001230.

    PMID: 29877907

This page provides educational information about pain management options for CMT1A. Always consult your neurologist or healthcare provider before starting, stopping, or adjusting any pain medications.

Get notified when new evidence is published on Charcot-Marie-Tooth disease type 1A.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.